Study Says Combined Drugs Can Shrink Tumour By 60 Percent In Bowel Cancer

Updated Jul 25, 2024 | 06:09 PM IST

SummaryA new study has found that combining the use of botanciiimab and balstilumab can reduce tumours caused by bowel cancer by 60%, marking the first time a durable response to immunotherapy has been reported in patients suffering from this condition.
close-up-medicine-containers-table

A new study has found that a combination of two drugs could enhance the immune system to treat one of the most common types of cancer in the world, bowel cancer. Also known as colorectal cancer, despite its widespread presence, the treatment options for this condition are limited. What the study specifically found was that this procedure could shrink the tumours caused by this condition by around 60%.

What Are The Drugs Involved

The trial involved the use of two immunotherapy drugs, botancilimab and balstilumab. It is a monoclonal antibody that works to stimulate the body's immune system to attack cancer. The study is a rather significant find, as it’s the first time that a consistent and durable response to immunotherapy has been reported in patients with solid MSS mCRC tumours.

The study was divided into several phases for more than 6 months. In the US trial, around around 101 patients with microsatile stable metastatic colorectal (MSS-mCRC) tumours showed a decrease . Around 61% of the patients experienced tumour shrinkage or stabilization after combined treatment with votancilumab and balstilumab. When it comes to downsides, diarrhea and fatigue were found to be the most common side effects or side effects of this drug.

These results are interesting and open to exploration. To date, immunotherapy has not been effective in patients with CNS-mCRC tumors. This study demonstrates the potential of the combination of botenlimab and balstilimab in the treatment of CNS mCRC, providing new hope for people diagnosed with colon cancer.

What Could This Mean For Bowel Cancer Treatment In The Future

The study is currently in the final stages of clinical trials, and the US Food and Drug Administration (FDA) hopes to quickly gain approval for its use because of the importance of this area that affects many people. The efficiency shown demonstrates the potential of botansilimab to contribute to broad antitumor immunity.

All in all, the combination of botensilimab and balstilimab represents a promising new direction in the treatment of colorectal cancer. This breakthrough could improve conditions for many patients worldwide and lights a new hope in the fight against this common disease. The results of this study show the effectiveness of immunotherapy in this field and how its potential to transform cancer treatment can only grow in the years to come.

End of Article

Cancer Postcode Lottery: What Is It And Why Is UK Govt Putting An End To It?

Updated Jan 24, 2026 | 01:09 PM IST

SummaryUK government plans to end the cancer postcode lottery, where access to treatments depends on location. Bureaucracy and funding approvals mean advanced therapies like SABR reach some hospitals but not others. A new National Cancer Plan will boost specialists in rural and coastal areas, cut inequalities, and speed diagnosis and care.
Cancer Postcode Lottery: What Is It And Why Is UK Govt Putting An End To It?

Credits: Canva

Cancer Postcode Lottery will soon be put to an end by the UK Government. Reports say that it will enable the rural population access to cancer specialists and treatments. Before getting into how it will help the rural population and people living in coastal areas to find it easier to see a cancer doctor, let us first understand what postcode lottery means.

What Is Cancer Postcode Lottery?

The term cancer postcode lottery refers to a situation where a cancer patient’s access to the latest and most effective treatments depends on where they live or which hospital they are treated at, rather than purely on medical need.

Based on the information you shared, senior cancer doctors in England are warning that this is happening because of bureaucratic hurdles within the NHS. Even though cancer care is supposed to be equitable across the country, in practice, not all hospitals can easily offer the same treatments.

How Does This Postcode Lotter Work?

Doctors say that some cutting-edge cancer treatments such as advanced radiotherapy techniques and newer immunotherapy drugs require separate funding approvals. Individual cancer centers often have to apply to NHS England for permission and money to use these treatments.

Larger, better-funded hospitals with more administrative resources are often able to navigate this complex system more easily. Smaller or less well-resourced units may struggle, meaning patients treated there may not get access to the same options.

For instance, Stereotactic Ablative Body Radiotherapy (SABR). SABR is a highly precise form of radiotherapy that delivers strong radiation doses directly to small tumors in areas such as the lungs, liver, brain and lymph nodes. Although SABR is a well-established treatment and can be life-saving for certain patients, the Royal College of Radiologists (RCR) says some cancer units still have to apply for special funding to use it. This leads to situations where a patient in one area can receive SABR, while another patient with the same cancer elsewhere cannot.

What Is The Government Planning To Do With Postcode Lottery?

As per the official website of UK Government, this will allow people "living in rural and coastal communities will find it easier to see a cancer specialist as part of plans to tackle the current postcode lottery."

The website notes that most deprived parts of the country have fewer cancer consultants, which leaves patients waiting longer for essential care. These same areas also face highest economic inactivity, with long waits for diagnosis and treatment keeping people out of work and holding back local economies. This is why the government is now introducing "new training places targeted at trusts with biggest workforce gaps, prioritising rural and coastal areas".

Working with the Royal Colleges, the government will encourage more doctors to train in clinical and medical oncology to increase the number of cancer specialists in underserved areas.

These steps will be outlined in the upcoming National Cancer Plan, which aims to speed up diagnosis and treatment, reduce inequalities, and support the goal of making England a global leader in cancer survival, while building a future-ready NHS.

End of Article

Could Red Light Therapy Help Protect Football Players From CTE

Updated Jan 24, 2026 | 11:32 AM IST

SummaryA new study suggests red light therapy may help protect football players from brain inflammation linked to CTE. In collegiate athletes, those using targeted red light devices showed no increase in brain inflammation over a season, unlike placebo users. Experts say the non-invasive therapy is promising but requires further research.
Could Red Light Therapy Help Protect Football Players From CTE

Credits: Canva

A treatment already popular in the US for skin care, pain relief, and faster healing may soon be known for something far more serious. A new study suggests red light therapy could help protect football players’ brains from chronic inflammation caused by repeated hits to the head.

Experts say the findings are early but promising, especially in the ongoing search for ways to reduce long term brain damage in contact sports.

What Is CTE?

Chronic traumatic encephalopathy, or CTE, is a degenerative brain disease linked to repeated head injuries. It is commonly found in former football players, boxers, and military personnel exposed to blast injuries. Over time, the condition can cause memory loss, confusion, mood changes, aggression, and eventually problems with movement, speech, swallowing, and breathing. There is currently no cure, and doctors still do not know how to slow its progression.

Why inflammation matters in CTE

For now, the only proven way to lower CTE risk is to reduce repeated brain trauma through better helmets, rule changes, and fewer hits to the head. But with more than 100 former NFL players diagnosed with CTE after death and many more suspected cases, experts agree that prevention tools alone are not enough.

Researchers believe chronic inflammation in the brain plays a major role in how CTE develops and worsens over time. If that inflammation can be reduced early, it could potentially limit long term damage.

Red light therapy, also known as photobiomodulation, has already been shown to reduce inflammation in other parts of the body. It works by stimulating energy production inside cells and improving blood flow, which helps tissues repair and recover.

Inside the football study

To see whether the therapy could help the brain, researchers at the University of Utah Health studied 26 collegiate football players during a full season. Half received active red light therapy using a light emitting headset and a small device placed inside the nose. The other half used an identical looking device that did not emit light.

Players completed three 20 minute sessions each week over 16 weeks. Brain scans were taken before and after the season.

Read: 21-year-old Billy Vigar Of Chichester City Dies Of Sustaining Brain Injury

The results were striking. MRI scans showed that players in the placebo group experienced a significant increase in brain inflammation by the end of the season. In contrast, those using red light therapy showed little to no increase, with protection seen across most brain regions.

Why experts are paying attention

Specialists who reviewed the findings say the results align with what scientists already understand about inflammation and brain injury. Reducing the inflammatory response after repeated impacts could help limit the damage that builds up over time.

Another advantage is that the therapy is non invasive and does not involve medication. Most users report no major side effects, which makes it especially appealing for athletes.

That said, experts caution against buying over the counter red light devices. The therapy requires very specific wavelengths that can penetrate skin and tissue effectively. Many consumer products do not meet those standards.

Researchers stress that more studies are needed to confirm long term safety and effectiveness. A large Department of Defense funded trial is already planned, involving 300 people with persistent concussion or traumatic brain injury symptoms, including veterans and first responders.

If future research continues to show benefits without harm, red light therapy could one day become part of how teams protect athletes’ brains, not just in football, but across many sports.

End of Article

Nicole 'Snooki' Polizzi Says Doctors Found Cancerous Cells In Her Cervix

Updated Jan 24, 2026 | 10:43 AM IST

SummaryNicole ‘Snooki’ Polizzi revealed a cervical cancer scare after abnormal Pap smears and cancerous cells on her cervix, urging women to get screened. The article also explains colorectal cancer, noting rising deaths among Americans under 50, now the leading cancer killer in that age group, according to American Cancer Society research.
Nicole 'Snooki' Polizzi Says Doctors Found Cancerous Cells In Her Cervix

Credits: Wikimedia Commons

Nicole "Snooki" Polizzi opened up about a cancer scare. Now, 38, the Jersey Shore star, posted on her TikTok an emotional video, where she explained that she has been dealing with abnormal pap smear results. She said that it has been about four year since the precancerous cells were found. Because of that she had to undergo an "uncomfortable" colposcopy and biopsy.

She said that when the results came back, the doctor informed her that her cervix is "Not looking great". The doctor had found cancerous cells on the top of her cervix. She said that she would soon need a cone biopsy under anesthesia for further testing. "I am terrified. It is scary, but we have to get it done because cervical cancer is nothing to joke about."

She said, "But whatever to keep me healthy and safe to be here for my kids that I have now," referring to her three children with her husband Jionni LaValle.

In her TikTok video, she said that she is scared and freaking out. She also said that she hopes to find community on social media with other women who have been through the same.

She also agreed to delaying her routine examination because of fear. "I waited on my appointments because I knew I might not get great results but also because I didn't want to feel the pain. I didn't want to deal with the stress of having to deal with all of this," she said.

Talking about her TikTok video, she said, “Just making this video to spread awareness to make sure you get your pap smears. And if your doctor calls you to do it again, do it, Make sure you are fine and prevent all the bad things that could happen, like cervical cancer." She said she was nervous but also shared that she received a lot of support from her friends and family. "Being a woman is not easy and is definitely a scary thing. I know I am going to be fine. It is just scary."

Read: Oncologist Reveals 5 Subtle Cervical Cancer Signs That You May Miss

What Is Cervical Cancer?

Cervical cancer develops in a women's cervix (uterus opening) due to abnormal cell growth, primarily caused by persistent HPV infection, a common infection that's passed through sexual contact.

When exposed to HPV, the body's immune system typically prevents the virus from causing damage however, in a small percentage of people, the virus can survive for years and pave the way for some cervical cells to become cancerous.

Treatment involves surgery, radiation, and chemotherapy, with early detection significantly improving outcomes, though it remains a major cancer in low-income countries. Cervical cancer can also be prevented through vaccination and regular screening (Pap/HPV tests).

Dr Ninad Katdare told News18: "In its early stages, it is often more of a whisper than a shout. As a cancer surgeon who has treated hundreds of women with gynaecological cancers, I can say with confidence that recognizing these subtle cues can lead to earlier diagnosis and significantly better outcomes."

End of Article